CP
RDHL

Corbenic Partners’s Redhill Biopharma RDHL Stock Holding History

Corbenic Partners’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Hold
0
– -$1K – 300
2021
Q2 		– Hold
0
– – – 246
2021
Q1 		– Sell
-1
Closed -$8.39K – 232
2020
Q4 		$4K Hold
1
– – ﹤0.01% 157
2020
Q3 		$5K Hold
1
– – ﹤0.01% 131
2020
Q2 		$3K Hold
1
– – ﹤0.01% 133
2020
Q1 		$2K Hold
1
– – ﹤0.01% 151
2019
Q4 		$3K Buy
+1
New +$6.39K ﹤0.01% 148

Other funds holding RDHL

DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Corbenic Partners's RDHL Position: Q3 2021 in Review

Corbenic Partners held its Redhill Biopharma (RDHL) position steady in Q3 2021 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #300.

Corbenic Partners first reported a position in RDHL in Q4 2019 and has held it in 5 quarters since. The position peaked at $5K in Q3 2020. 53 funds tracked by Wall St. Rank hold RDHL as of Q3 2021.

  • Corbenic Partners held 0 shares of Redhill Biopharma worth $0 as of Q3 2021.
  • Corbenic Partners left its Redhill Biopharma share count unchanged in Q3 2021.
  • Redhill Biopharma made up ﹤0.01% of Corbenic Partners's portfolio in Q3 2021, its #300 holding.
  • Corbenic Partners first reported a position in Redhill Biopharma in Q4 2019 and has held it in 5 quarters since.
  • Corbenic Partners's Redhill Biopharma position peaked at $5K in Q3 2020.
  • 53 funds tracked by Wall St. Rank held Redhill Biopharma as of Q3 2021.

Based on Corbenic Partners's 13F filing for Q3 2021, filed 13 Oct 2021.